Cynosure, Inc. (NASDAQ:CYNO)

CAPS Rating: 2 out of 5

The Company develops and markets aesthetic treatment systems to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular lesions and temporarily reduce the appearance of cellulite.

Recs

1
Player Avatar AikenDrumm (< 20) Submitted: 1/11/2008 5:33:07 PM : Outperform Start Price: $25.43 CYNO Score: -58.00

This stock has been beaten down by fears of a recession and decreased spending, but they are not selling to the general public, and demand for their new plastic surgery equipment is growing.

Featured Broker Partners


Advertisement